Clinical significance of the integrin α6β4 in human malignancies

Hynes, 2002, Integrins: bidirectional, allosteric signaling machines, Cell, 110, 673, 10.1016/S0092-8674(02)00971-6 Guo, 2004, Integrin signalling during tumour progression, Nat Rev Mol Cell Biol, 5, 816, 10.1038/nrm1490 Barczyk, 2010, Integrins, Cell Tissue Res, 339, 269, 10.1007/s00441-009-0834-6 Lipscomb, 2005, Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression, Cancer Metastasis Rev, 24, 413, 10.1007/s10555-005-5133-4 Nikolopoulos, 2004, Integrin beta4 signaling promotes tumor angiogenesis, Cancer Cell, 6, 471, 10.1016/j.ccr.2004.09.029 Shaw, 1997, Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion, Cell, 91, 949, 10.1016/S0092-8674(00)80486-9 Rabinovitz, 1999, Protein kinase C-dependent mobilization of the alpha6beta4 integrin from hemidesmosomes and its association with actin-rich cell protrusions drive the chemotactic migration of carcinoma cells, J Cell Biol, 146, 1147, 10.1083/jcb.146.5.1147 Mainiero, 1996, The intracellular functions of alpha6beta4 integrin are regulated by EGF, J Cell Biol, 134, 241, 10.1083/jcb.134.1.241 O'Connor, 1998, Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells, J Cell Biol, 143, 1749, 10.1083/jcb.143.6.1749 Hogervorst, 1990, Cloning and sequence analysis of beta-4 cDNA: an integrin subunit that contains a unique 118 kd cytoplasmic domain, EMBO J, 9, 765, 10.1002/j.1460-2075.1990.tb08171.x Suzuki, 1990, Amino acid sequence of a novel integrin beta 4 subunit and primary expression of the mRNA in epithelial cells, EMBO J, 9, 757, 10.1002/j.1460-2075.1990.tb08170.x de Pereda, 1999, Crystal structure of a tandem pair of fibronectin type III domains from the cytoplasmic tail of integrin alpha6beta4, EMBO J, 18, 4087, 10.1093/emboj/18.15.4087 Litjens, 2006, Current insights into the formation and breakdown of hemidesmosomes, Trends Cell Biol, 16, 376, 10.1016/j.tcb.2006.05.004 Margadant, 2008, Regulation of hemidesmosome disassembly by growth factor receptors, Curr Opin Cell Biol, 20, 589, 10.1016/j.ceb.2008.05.001 de Pereda, 2009, Advances and perspectives of the architecture of hemidesmosomes: lessons from structural biology, Cell Adh Migr, 3, 361, 10.4161/cam.3.4.9525 Borradori, 1996, Hemidesmosomes: roles in adhesion, signaling and human diseases, Curr Opin Cell Biol, 8, 647, 10.1016/S0955-0674(96)80106-2 Rezniczek, 1998, Linking integrin alpha6beta4-based cell adhesion to the intermediate filament cytoskeleton: direct interaction between the beta4 subunit and plectin at multiple molecular sites, J Cell Biol, 141, 209, 10.1083/jcb.141.1.209 Vidal, 1995, Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia, Nat Genet, 10, 229, 10.1038/ng0695-229 Dowling, 1996, Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival, J Cell Biol, 134, 559, 10.1083/jcb.134.2.559 Tsuruta, 2011, Hemidesmosomes and focal contact proteins: functions and cross-talk in keratinocytes, bullous diseases and wound healing, J Dermatol Sci, 62, 1 Mariotti, 2001, EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion, J Cell Biol., 155, 447, 10.1083/jcb.200105017 Rabinovitz, 1997, The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures, J Cell Biol, 139, 1873, 10.1083/jcb.139.7.1873 O'Connor, 2012, Integrin alpha6beta4 cooperates with LPA signaling to stimulate Rac through AKAP-Lbc-mediated RhoA activation, Am J Physiol Cell Physiol, 302, C605, 10.1152/ajpcell.00095.2011 O'Connor, 2000, RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism, J Cell Biol, 148, 253, 10.1083/jcb.148.2.253 Werner, 2007, Caspase proteolysis of the integrin beta4 subunit disrupts hemidesmosome assembly, promotes apoptosis, and inhibits cell migration, J Biol Chem, 282, 5560, 10.1074/jbc.M603669200 Beausejour, 2013, Suppression of anoikis in human intestinal epithelial cells: differentiation state-selective roles of alpha2beta1, alpha3beta1, alpha5beta1, and alpha6beta4 integrins, BMC Cell Biol, 14, 53, 10.1186/1471-2121-14-53 Guo, 2006, Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis, Cell, 126, 489, 10.1016/j.cell.2006.05.047 Trusolino, 2001, A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth, Cell, 107, 643, 10.1016/S0092-8674(01)00567-0 Chung, 2004, The Met receptor and alpha 6 beta 4 integrin can function independently to promote carcinoma invasion, J Biol Chem, 279, 32287, 10.1074/jbc.M403809200 Folgiero, 2007, The alpha6beta4 integrin can regulate ErbB-3 expression: implications for alpha6beta4 signaling and function, Cancer Res, 67, 1645, 10.1158/0008-5472.CAN-06-2980 Bachelder, 1999, p53 inhibits alpha 6 beta 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB, J Cell Biol, 147, 1063, 10.1083/jcb.147.5.1063 Mainiero, 1997, The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation, EMBO J, 16, 2365, 10.1093/emboj/16.9.2365 Jauliac, 2002, The role of NFAT transcription factors in integrin-mediated carcinoma invasion, Nat Cell Biol, 4, 540, 10.1038/ncb816 Chen, 2005, Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells, Oncogene, 24, 5125, 10.1038/sj.onc.1208729 Chen, 2009, Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin, J Biol Chem, 284, 1484, 10.1074/jbc.M803997200 Santoro, 2003, The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration, Dev Cell, 5, 257, 10.1016/S1534-5807(03)00201-6 Chao, 1996, A function for the integrin alpha6beta4 in the invasive properties of colorectal carcinoma cells, Cancer Res, 56, 4811 Yuan, 2008, PI3K pathway alterations in cancer: variations on a theme, Oncogene, 27, 5497, 10.1038/onc.2008.245 Gambaletta, 2000, Cooperative signaling between alpha(6)beta(4) integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion, J Biol Chem, 275, 10604, 10.1074/jbc.275.14.10604 Gagnoux-Palacios, 2003, Compartmentalization of integrin alpha6beta4 signaling in lipid rafts, J Cell Biol, 162, 1189, 10.1083/jcb.200305006 Bhatia, 2009, Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling, Mol Cancer Res, 7, 1119, 10.1158/1541-7786.MCR-08-0568 Shaw, 2001, Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion, Mol Cell Biol, 21, 5082, 10.1128/MCB.21.15.5082-5093.2001 Machacek, 2009, Coordination of Rho GTPase activities during cell protrusion, Nature, 461, 99, 10.1038/nature08242 Zahir, 2003, Autocrine laminin-5 ligates α6β4 integrin and activates RAC and NFκB to mediate anchorage-independent survival of mammary tumors, J Cell Biol, 163, 1397, 10.1083/jcb.200302023 Cruz-Monserrate, 2008, Integrin α6β4 promotes migration, invasion through Tiam1 upregulation and subsequent Rac activation, Neoplasia, 10, 408, 10.1593/neo.07868 O'Connor, 2013, Dynamic functions of RhoA in tumor cell migration and invasion, Small GTPases, 4, 1, 10.4161/sgtp.25131 Chen, 2013, Coupling S100A4 to Rhotekin alters Rho signaling output in breast cancer cells, Oncogene, 32, 3754, 10.1038/onc.2012.383 Soung, 2011, Curcumin inhibition of the functional interaction between integrin alpha6beta4 and the epidermal growth factor receptor, Mol Cancer Ther, 10, 883, 10.1158/1535-7163.MCT-10-1053 Falcioni, 1997, Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines, Exp Cell Res, 236, 76, 10.1006/excr.1997.3695 Lu, 2008, Analysis of integrin beta4 expression in human breast cancer: association with basal-like tumors and prognostic significance, Clin Cancer Res, 14, 1050, 10.1158/1078-0432.CCR-07-4116 Folgiero, 2008, Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas, PLoS One, 3, e1592, 10.1371/journal.pone.0001592 Gilcrease, 2009, Coexpression of alpha6beta4 integrin and guanine nucleotide exchange factor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis, Cancer Epidemiol Biomarkers Prev, 18, 80, 10.1158/1055-9965.EPI-08-0842 Diaz, 2005, Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer, Mod Pathol, 18, 1165, 10.1038/modpathol.3800411 Yoon, 2006, A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling, Cancer Res, 66, 2732, 10.1158/0008-5472.CAN-05-2941 Akiyama, 1986, The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity, Science, 232, 1644, 10.1126/science.3012781 Roy, 2009, Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer, Oncologist, 14, 1061, 10.1634/theoncologist.2009-0142 Olayioye, 2000, The ErbB signaling network: receptor heterodimerization in development and cancer, EMBO J, 19, 3159, 10.1093/emboj/19.13.3159 Wallasch, 1995, Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3, EMBO J, 14, 4267, 10.1002/j.1460-2075.1995.tb00101.x Hellyer, 1998, ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase, Biochem J, 333, 757, 10.1042/bj3330757 Yu, 2012, The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome, Int J Cancer, 131, 1744, 10.1002/ijc.27447 Thomas, 2007, The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression, Cancer Res, 67, 6075, 10.1158/0008-5472.CAN-06-4128 Logan-Collins, 2010, Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers, Cancer Res, 70, 1130, 10.1158/0008-5472.CAN-09-0761 Ruoslahti, 1994, Anchorage dependence, integrins, and apoptosis, Cell, 77, 477, 10.1016/0092-8674(94)90209-7 Kim, 1997, Beta 4 integrin transfection of UM-UC-2 (human bladder carcinoma) cells: stable expression of a spontaneous cytoplasmic truncation mutant with rapid loss of clones expressing intact beta 4, Cancer Res, 57, 38 Clarke, 1995, Activation of the p21 pathway of growth arrest and apoptosis by the beta 4 integrin cytoplasmic domain, J Biol Chem, 270, 22673, 10.1074/jbc.270.39.22673 Sun, 1998, Downstream events in mammary gland morphogenesis mediated by reexpression of the alpha2beta1 integrin: the role of the alpha6 and beta4 integrin subunits, Cancer Res, 58, 2224 Lv, 2008, Knockdown of integrin beta4 in primary cultured mouse neurons blocks survival and induces apoptosis by elevating NADPH oxidase activity and reactive oxygen species level, Int J Biochem Cell Biol, 40, 689, 10.1016/j.biocel.2007.10.006 Lipscomb, 2005, The alpha6beta4 integrin maintains the survival of human breast carcinoma cells in vivo, Cancer Res, 65, 10970, 10.1158/0008-5472.CAN-05-2327 Bachelder, 1999, Activation of p53 function in carcinoma cells by the alpha6beta4 integrin, J Biol Chem, 274, 20733, 10.1074/jbc.274.29.20733 Cancer Genome Atlas Network, 2012, Comprehensive molecular portraits of human breast tumours, Nature, 490, 61, 10.1038/nature11412 Rakha, 2008, Basal-like breast cancer: a critical review, J Clin Oncol, 26, 2568, 10.1200/JCO.2007.13.1748 Cruz-Monserrate, 2007, Upregulation and redistribution of integrin alpha6beta4 expression occurs at an early stage in pancreatic adenocarcinoma progression, Mod Pathol, 20, 656, 10.1038/modpathol.3800782 Cancer Genome Atlas Research Network, 2011, Integrated genomic analyses of ovarian carcinoma, Nature, 474, 609, 10.1038/nature10166 Skubitz, 1996, Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin, Am J Pathol, 148, 1445 Bridges, 1995, Expression of integrin adhesion molecules in normal ovary and epithelial ovarian tumors, Int J Gynecol Cancer, 5, 187, 10.1046/j.1525-1438.1995.05030187.x Pellegata, 1994, K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions, Cancer Res, 54, 1556 Giancotti, 2007, Targeting integrin beta4 for cancer and anti-angiogenic therapy, Trends Pharmacol Sci, 28, 506, 10.1016/j.tips.2007.08.004 Wang, 2012, The roles of integrin beta4 in vascular endothelial cells, J Cell Physiol, 227, 474, 10.1002/jcp.22769 Houben, 2011, Autotaxin and LPA receptor signaling in cancer, Cancer Metastasis Rev, 30, 557, 10.1007/s10555-011-9319-7 Boye, 2010, S100A4 and metastasis: a small actor playing many roles, Am J Pathol, 176, 528, 10.2353/ajpath.2010.090526 Gerson, 2012, Effects of beta4 integrin expression on microRNA patterns in breast cancer, Biol Open, 1, 658, 10.1242/bio.20121628 Falcioni, 1988, Monoclonal antibody to human carcinoma-associated protein complex: quantitation in normal and tumor tissue, Cancer Res, 48, 816 Kimmel, 1986, Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9, Cancer Res, 46, 3614 Kennel, 1989, Analysis of the tumor-associated antigen TSP-180. Identity with alpha 6-beta 4 in the integrin superfamily, J Biol Chem, 264, 15515, 10.1016/S0021-9258(19)84860-3 Van Waes, 1991, The A9 antigen associated with aggressive human squamous carcinoma is structurally and functionally similar to the newly defined integrin alpha 6 beta 4, Cancer Res, 51, 2395 Tagliabue, 1998, Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells, Clin Cancer Res, 4, 407 Koukoulis, 1991, Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules, Am J Pathol, 139, 787 Pignatelli, 1992, Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors, Hum Pathol, 23, 1159, 10.1016/0046-8177(92)90034-Z Natali, 1992, Changes in expression of alpha 6/beta 4 integrin heterodimer in primary and metastatic breast cancer, Br J Cancer, 66, 318, 10.1038/bjc.1992.263 Hanby, 1993, Beta 1 and beta 4 integrin expression in methacarn and formalin-fixed material from in situ ductal carcinoma of the breast, J Pathol, 171, 257, 10.1002/path.1711710405 Grossman, 1992, Alterations in antigen expression in superficial bladder cancer, J Cell Biochem Suppl, 16I, 63, 10.1002/jcb.240501313 Grossman, 2000, Expression of the alpha6beta4 integrin provides prognostic information in bladder cancer, Oncol Rep, 7, 13 Behnsawy, 2011, Expression of integrin proteins in non-muscle-invasive bladder cancer: significance of intravesical recurrence after transurethral resection, BJU Int, 107, 240, 10.1111/j.1464-410X.2010.09534.x Carico, 1993, Integrin beta 4 expression in the neoplastic progression of cervical epithelium, Gynecol Oncol, 49, 61, 10.1006/gyno.1993.1087 Aplin, 1996, Abnormal expression of integrin alpha 6 beta 4 in cervical intraepithelial neoplasia, Br J Cancer, 74, 240, 10.1038/bjc.1996.344 Jeffers, 1997, E-cadherin and integrin cell adhesion molecule expression in invasive and in situ carcinoma of the cervix, Gynecol Oncol, 64, 481, 10.1006/gyno.1996.4578 Wolf, 1990, Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck, J Natl Cancer Inst, 82, 1566, 10.1093/jnci/82.19.1566 Eriksen, 2004, Expression of integrins and E-cadherin in squamous cell carcinomas of the head and neck, APMIS, 112, 560, 10.1111/j.1600-0463.2004.apm1120902.x Kurokawa, 2008, Diagnostic value of integrin alpha3, beta4, and beta5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma, Cancer, 112, 1272, 10.1002/cncr.23295 Nagata, 2013, ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma, BMC Cancer, 13, 410, 10.1186/1471-2407-13-410 Mariani Costantini, 1990, Integrin (alpha 6/beta 4) expression in human lung cancer as monitored by specific monoclonal antibodies, Cancer Res, 50, 6107 Koukoulis, 1997, Immunolocalization of integrins in the normal lung and in pulmonary carcinomas, Hum Pathol, 28, 1018, 10.1016/S0046-8177(97)90054-X Patriarca, 1998, Integrin laminin receptor profile of pulmonary squamous cell and adenocarcinomas, Hum Pathol, 29, 1208, 10.1016/S0046-8177(98)90247-7 Boelens, 2007, Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus, J Clin Pathol, 60, 608, 10.1136/jcp.2005.031443 Logsdon, 2003, Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer, Cancer Res, 63, 2649 Crnogorac-Jurcevic, 2003, Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent, J Pathol, 201, 63, 10.1002/path.1418 Gleason, 2005, Immunohistochemical detection of the beta4 integrin subunit in pancreatic adenocarcinoma, J Histochem Cytochem, 53, 799, 10.1369/jhc.4B6522.2005 Hruban, 2008, Update on pancreatic intraepithelial neoplasia, Int J Clin Exp Pathol, 1, 306 Masugi, 2015, Upregulation of integrin beta4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma, Lab Invest, 95, 308, 10.1038/labinvest.2014.166 Serini, 1996, Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue, J Natl Cancer Inst, 88, 442, 10.1093/jnci/88.7.442 Montuori, 1999, Laminin receptors in differentiated thyroid tumors: restricted expression of the 67-kilodalton laminin receptor in follicular carcinoma cells, J Clin Endocrinol Metab, 84, 2086 Dahlman, 1998, Integrins in thyroid tissue: upregulation of alpha2beta1 in anaplastic thyroid carcinoma, Eur J Endocrinol, 138, 104, 10.1530/eje.0.1380104 Kitajiri, 2002, Increased expression of integrin beta-4 in papillary thyroid carcinoma with gross lymph node metastasis, Pathol Int, 52, 438, 10.1046/j.1440-1827.2002.01379.x Stallmach, 1992, Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation, Gut, 33, 342, 10.1136/gut.33.3.342 Sordat, 1998, Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia, J Pathol, 185, 44, 10.1002/(SICI)1096-9896(199805)185:1<44::AID-PATH46>3.0.CO;2-A Falcioni, 1994, Integrin beta-4 expression in colorectal-cancer, Int J Oncol, 5, 573 Ni, 2005, Upregulation of a functional form of the beta4 integrin subunit in colorectal cancers correlates with c-Myc expression, Oncogene, 24, 6820, 10.1038/sj.onc.1208848 Knox, 1994, Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate, Am J Pathol, 145, 167 Cress, 1995, The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression, Cancer Metastasis Rev., 14, 219, 10.1007/BF00690293 Davis, 2001, Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma, Prostate, 46, 240, 10.1002/1097-0045(20010215)46:3<240::AID-PROS1029>3.0.CO;2-0 Nagle, 1995, Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue, Am J Pathol, 146, 1498 Allen, 1998, Downregulation of the beta4 integrin subunit in prostatic carcinoma and prostatic intraepithelial neoplasia, Hum Pathol, 29, 311, 10.1016/S0046-8177(98)90109-5 Bonaccorsi, 2000, Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype, Endocrinology, 141, 3172, 10.1210/endo.141.9.7640 Yoshioka, 2013, beta4 Integrin signaling induces expansion of prostate tumor progenitors, J Clin Invest, 123, 682 Chakraborty, 2015 Previtali, 1996, Alpha6 beta4 and alpha6 beta1 integrins in astrocytomas and other CNS tumors, J Neuropathol Exp Neurol, 55, 456, 10.1097/00005072-199604000-00008 Paulus, 1993, Characterization of integrin receptors in normal and neoplastic human brain, Am J Pathol, 143, 154 Belot, 2001, Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features, Glia, 36, 375, 10.1002/glia.1124 Wan, 2009, Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin, Oncogene, 28, 3401, 10.1038/onc.2009.206 Mechtersheimer, 1994, In situ expression of beta 1, beta 3 and beta 4 integrin subunits in non-neoplastic endothelium and vascular tumours, Virchows Arch, 425, 375, 10.1007/BF00189575 Barth, 1995, Differential expression of beta 1, beta 3 and beta 4 integrins in sarcomas of the small, round, blue cell category, Virchows Arch, 426, 19, 10.1007/BF00194694